Vapotherm Inc VAPO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VAPO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.80
- Day Range
- $0.82–0.82
- 52-Week Range
- $0.70–5.44
- Bid/Ask
- $0.75 / $0.97
- Market Cap
- $5.10 Mil
- Volume/Avg
- 7,502 / 8,869
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Precision Flow Heliox and others. It generates revenue from sales of products to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 207
- Website
- https://www.vapotherm.com
Valuation
|
Metric
|
VAPO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.07 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VAPO
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.30 |
Interest Coverage | −1.32 |
Quick Ratio
VAPO
Profitability
|
Metric
|
VAPO
|
|---|---|
Return on Assets (Normalized) | −56.38% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −45.82% |
Return on Assets
VAPO
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Ynbymwj | Csgrnl | $180.4 Bil | |||
| Stryker Corp
SYK
| Bbfphktxc | Lshdj | $131.4 Bil | |||
| Boston Scientific Corp
BSX
| Hqftgcc | Yzhfgg | $112.9 Bil | |||
| Medtronic PLC
MDT
| Mlgsqvl | Mbslg | $106.3 Bil | |||
| Edwards Lifesciences Corp
EW
| Kfnbmvszcw | Mflspw | $52.6 Bil | |||
| DexCom Inc
DXCM
| Gqrzsqbch | Ywzl | $45.9 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Dtfhnrpd | Kffcl | $24.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Grhrwkcg | Xhh | $22.1 Bil | |||
| Steris PLC
STE
| Dhtpmjdwz | Lnlhw | $21.6 Bil | |||
| Align Technology Inc
ALGN
| Gqdhtxnw | Bzbps | $19.3 Bil |